Cochrane · systematic review · CD001487
Graft type for femoro‐popliteal bypass surgery
Ambler, GK, Twine, CP · Cochrane Database of Systematic Reviews · 2018 · Cochrane Library
VascularAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
16
current version
GRADE rated
12
No studies
4
Included studies
NR
No studies 4 · 25%Ungraded 0 · 0%Very low 2 · 12.5%Low 9 · 56.3%Moderate 1 · 6.3%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Autologous vein compared to other graft types for above‐knee femoro‐popliteal bypass surgery
Population: people with peripheral vascular disease requiring above‐knee femoro‐popliteal bypass surgery
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Primary patency (24 months) Autologous vein vs other graft types | OR 0.59 [0.37, 0.94] | NR | Low Downgraded: risk of bias, imprecision |
Primary patency (60 months) Autologous vein vs other graft types | OR 0.47 [0.28, 0.8] | NR | Moderate Downgraded: risk of bias, imprecision |
Secondary patency (60 months) Autologous vein vs other graft types | OR 0.41 [0.22, 0.74] | NR | Low Downgraded: risk of bias, imprecision |
Limb salvage Autologous vein vs other graft types | no estimate extracted | NR | No studies |
PTFE compared to Dacron for above‐knee femoro‐popliteal bypass surgery
Population: people with peripheral vascular disease requiring above‐knee femoro‐popliteal bypass surgery
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Primary patency (24 months) PTFE vs Dacron | OR 1.23 [0.92, 1.65] | NR | Low Downgraded: risk of bias, imprecision |
Primary patency (60 months) PTFE vs Dacron | OR 1.67 [0.96, 2.9] | NR | Low Downgraded: risk of bias, imprecision |
Secondary patency (24 months) PTFE vs Dacron | OR 1.54 [1.04, 2.28] | NR | Low Downgraded: risk of bias, imprecision |
Limb salvage (24 months) PTFE vs Dacron | OR 0.82 [0.27, 2.48] | NR | Low Downgraded: risk of bias, imprecision |
Externally supported graft compared to unsupported graft for above‐knee femoro‐popliteal bypass surgery
Population: people with peripheral vascular disease requiring above‐knee femoro‐popliteal bypass surgery
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Primary patency (24 months) Externally supported graft vs unsupported graft | OR 2.08 [1.29, 3.35] | NR | Low Downgraded: risk of bias, imprecision |
Primary patency (60 months) Externally supported graft vs unsupported graft | no estimate extracted | NR | No studies |
Secondary patency (24 months) Externally supported graft vs unsupported graft | OR 2.25 [1.24, 4.07] | NR | Low Downgraded: risk of bias, imprecision |
Limb salvage Externally supported graft vs unsupported graft | no estimate extracted | NR | No studies |
PTFE compared to PTFE with vein cuff for below‐knee femoro‐popliteal bypass surgery
Population: people with peripheral vascular disease requiring below‐knee femoro‐popliteal bypass surgery
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Primary patency (24 months) PTFE vs PTFE with vein cuff | OR 1.08 [0.58, 2.01] | NR | Very low Downgraded: risk of bias, imprecision, inconsistency |
Primary patency (60 months) PTFE vs PTFE with vein cuff | no estimate extracted | NR | No studies |
Secondary patency (24 months) PTFE vs PTFE with vein cuff | OR 1.22 [0.67, 2.23] | NR | Very low Downgraded: risk of bias, imprecision, inconsistency |
Limb salvage (24 months) PTFE vs PTFE with vein cuff | OR 1.34 [0.72, 2.49] | NR | Low Downgraded: risk of bias, imprecision |